Clinical, laboratory, and pacing predictors of CRT response.

Journal of Cardiovascular Translational Research
Jagdesh KandalaJagmeet P Singh

Abstract

A decade of research has established the role of cardiac resynchronization therapy (CRT) in medically refractory, moderate to severe systolic heart failure (HF) with intraventricular conduction delay. CRT is an electrical therapy instituted to reestablish ventricular synchronization in order to improve cardiac function and favorably modulate the neurohormonal system. CRT confers a mortality benefit, improved HF hospitalizations, and functional outcome in this population, but not all patients consistently demonstrate a positive CRT response. The nonresponder rate varies from 20% to 40%, depending on the defined response criteria. Efforts to improve response to CRT have focused on a number of fronts. Methods to optimize the correction of electrical and mechanical dyssynchrony, which is the primary target of CRT, has been the focus of research, in addition to improving patient selection and optimizing post-implant care. However, a major issue in dealing with improving nonresponse rates has been finding an accurate and generally accepted definition of "response" itself. The availability of a standard consensus definition of CRT response would enable the estimation of nonresponder burden accurately and permit the development of stra...Continue Reading

References

May 11, 1979·JAMA : the Journal of the American Medical Association·W B Kannel, D L McGee
Dec 19, 1998·Journal of the American College of Cardiology·C LeclercqJ C Daubert
Jan 5, 2001·Pacing and Clinical Electrophysiology : PACE·I LozanoUNKNOWN VENTAK CHF/CONTAK CD Investigators Study Group
Mar 7, 2001·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·P RitterG Gaggini
Mar 22, 2001·The New England Journal of Medicine·S CazeauUNKNOWN Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators
Dec 19, 2001·Circulation·C ButterUNKNOWN Pacing Therapy for Chronic Heart Failure II Study Group
Jun 14, 2002·The New England Journal of Medicine·William T AbrahamUNKNOWN MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation
Jun 27, 2002·Journal of the American College of Cardiology·Angelo AuricchioUNKNOWN Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group
Aug 3, 2002·Archives of Internal Medicine·Asefeh HeiatHarlan M Krumholz
Nov 13, 2002·Journal of the American College of Cardiology·Maria Vittoria PitzalisPaolo Rizzon
Apr 12, 2003·Pacing and Clinical Electrophysiology : PACE·S CazeauP Ritter
May 16, 2003·The New England Journal of Medicine·Mariell Jessup, Susan Brozena
May 29, 2003·JAMA : the Journal of the American Medical Association·James B YoungUNKNOWN Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators
May 21, 2004·The New England Journal of Medicine·Michael R BristowUNKNOWN Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators
Sep 1, 2004·Journal of the American College of Cardiology·G Michael FelkerChristopher M O'Connor
Nov 3, 2004·Journal of the American College of Cardiology·Jeroen J BaxMartin J Schalij
Dec 8, 2004·Journal of the American College of Cardiology·Pierre BordacharJacques Clementy
Feb 11, 2005·European Journal of Heart Failure·Peter J CowburnJohn D Parker
Mar 9, 2005·The New England Journal of Medicine·John G F ClelandUNKNOWN Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators
Sep 29, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Marc VanderheydenMarc Goethals
Nov 9, 2005·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Arthur J MossWojciech Zareba
Dec 16, 2005·Current Opinion in Cardiology·David H Birnie, Anthony Sl Tang
Dec 20, 2005·Journal of the American College of Cardiology·Jeroen J BaxCheuk-Man Yu
Dec 20, 2005·Journal of the American College of Cardiology·Gregory M MarcusUNKNOWN VENTAK CHF/CONTAK-CD Biventricular Pacing Study Investigators
Dec 20, 2005·Journal of the American College of Cardiology·Berry M van GelderNico H J Pijls
Jan 13, 2006·Pacing and Clinical Electrophysiology : PACE·Gabe B BleekerJeroen J Bax
Jan 31, 2006·The American Journal of Cardiology·Gabe B BleekerCheuk-Man Yu
Mar 7, 2006·The American Journal of Cardiology·Bàrbara VidalLluís Mont
Aug 8, 2006·International Journal of Cardiology·Stefan E HardtHelmut F Kuecherer
Aug 15, 2006·Journal of Cardiovascular Electrophysiology·Gabe B BleekerJeroen J Bax

❮ Previous
Next ❯

Citations

Jun 12, 2013·Heart Failure Reviews·A M ScholtensH J Verberne
Jun 7, 2014·Journal of Cardiovascular Electrophysiology·Abhishek BoseJagmeet P Singh
Jul 21, 2015·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Victor NauffalAlan Cheng
Apr 4, 2015·Heart Failure Clinics·Neal A Chatterjee, Jagmeet P Singh
Jan 22, 2015·Journal of Cardiovascular Translational Research·Enrique Lara-PezziAndreas M Zeiher
Mar 7, 2018·Current Treatment Options in Cardiovascular Medicine·Neal A Chatterjee, E Kevin Heist
Dec 7, 2013·Journal of the American Heart Association·Satsuki YamadaAndre Terzic
Dec 10, 2017·Pacing and Clinical Electrophysiology : PACE·Kebei LiJiangang Zou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.